BRKR
Bruker Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow -30.0% ·
net new positions -8.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 38.48K | $1.97M | n/a | n/a |
| Q2 2026 | 119 | +10 | 81.03M | $4.87B | +18 | −7 |
| Q1 2026 | 111 | -2 | 77.83M | $2.81B | +8 | −11 |
| Q4 2025 | 114 | +1 | 81.30M | $3.83B | +4 | −2 |
| Q3 2025 | 19 | 0 | 49.38M | $1.60B | +3 | −4 |
| Q2 2025 | 17 | +3 | 44.89M | $1.85B | +4 | −1 |
| Q1 2025 | 11 | 0 | 11.41M | $475.20M | +3 | −3 |
| Q4 2024 | 11 | -2 | 10.42M | $610.89M | +1 | −3 |
| Q3 2024 | 12 | -1 | 5.68M | $392.44M | n/a | −1 |
| Q2 2024 | 13 | n/a | 8.60M | $549.04M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.99M | +10.8% | $137.70M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 1.14M | +8.3% | $78.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 750.09K | +35.0% | $51.80M | 0.1% | ▲ Add | 2 | SEC ↗ ×3 |
| 4 | Millennium Management ✦ | 709.33K | +207.8% | $48.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 529.65K | -31.6% | $36.58M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Point72 Asset Management ✦ | 243.80K | -57.4% | $16.84M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 224.92K | +56.7% | $15.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 43.09K | -0.6% | $2.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 22.84K | -98.8% | $1.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 17.00K | -98.8% | $1.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 6.38K | -0.7% | $440,464 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 2.96K | -93.2% | $204,556 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| D. E. Shaw & Co. | $1.17M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 339 holders, 136.43M shares, $4.78B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.00K sh · $105,740
Officer · 3.47K sh · $197,614
Officer · 2.00K sh · $115,200
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology